STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 96 filers reported holding STOKE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $942,842 | -68.5% | 239,300 | -15.1% | 0.00% | -69.2% |
Q2 2023 | $2,995,534 | -8.5% | 281,800 | -28.3% | 0.01% | -27.8% |
Q1 2023 | $3,273,690 | -17.2% | 393,000 | -8.2% | 0.02% | -5.3% |
Q4 2022 | $3,952,286 | -65.7% | 428,200 | -52.3% | 0.02% | -66.1% |
Q3 2022 | $11,516,000 | -4.3% | 896,900 | -1.6% | 0.06% | +5.7% |
Q2 2022 | $12,036,000 | -57.2% | 911,100 | -31.8% | 0.05% | -45.4% |
Q1 2022 | $28,133,000 | +21540.8% | 1,336,500 | +26105.9% | 0.10% | – |
Q3 2021 | $130,000 | – | 5,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |